Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03226301
Brief Title: A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations

First Submitted : May 15, 2017
First Submitted that Met QC Criteria : July 20, 2017
First Posted : July 21, 2017

Last Update Submitted that Met QC Criteria : May 13, 2019
Last Update Posted : May 14, 2019